APA (7th ed.) Citation

T, S., T, M., M, Y., T, N., Y, K., Y, T., . . . A, T. (2021). Pathological eradication of recurrent metastatic renal cell carcinoma with sarcomatoid component by nivolumab plus ipilimumab combination therapy. International cancer conference journal, 10(4), 285. https://doi.org/10.1007/s13691-021-00501-2

Chicago Style (17th ed.) Citation

T, Sejima, Masago T, Yoshida M, Nishi T, Kawabata Y, Tajima Y, Yumioka T, Honda M, and Takenaka A. "Pathological Eradication of Recurrent Metastatic Renal Cell Carcinoma with Sarcomatoid Component by Nivolumab Plus Ipilimumab Combination Therapy." International Cancer Conference Journal 10, no. 4 (2021): 285. https://doi.org/10.1007/s13691-021-00501-2.

MLA (9th ed.) Citation

T, Sejima, et al. "Pathological Eradication of Recurrent Metastatic Renal Cell Carcinoma with Sarcomatoid Component by Nivolumab Plus Ipilimumab Combination Therapy." International Cancer Conference Journal, vol. 10, no. 4, 2021, p. 285, https://doi.org/10.1007/s13691-021-00501-2.